The US-based biotech company has submitted an application to the Saudi Food and Drug Authority (SFDA) for Breakthrough Medicine Designation, a fast-track regulatory pathway that could make Multikine ...

Drugs that boost the body’s immune system to fight disease are showing promise in treating a variety of cancers in earlier ...

CHICAGO – The postoperative addition of nivolumab (Opdivo) to chemoradiotherapy (CRT) extended disease-free survival (DFS) in ...

Colon cancer is the third most prevalent form of cancer in the U.S., and while screening has helped detect and prevent colon ...

A large prospective, randomized clinical trial in patients with advanced breast cancer has found that the use of liquid ...

A new study published by The New England Journal of Medicine on Sunday shows that adding an exercise program to recovery plans following treatment for colon cancer increased survival rates. Newsweek ...

Colon cancer is the third most prevalent form of cancer in the U.S., and while screening has helped detect and prevent colon ...

Doctors might use programmes like this to predict how well particular treatments may work for you. Cancer survival means the percentage of people still alive after a particular amount of time.

USA: Researchers have found in a cohort study that long-term survival rates were similar between patients undergoing simple ...

Johnson & Johnson announced today new data from a Phase 1 study evaluating pasritamig (JNJ-78278343), a first-in-class bispecific antibody that activates T-cells to harness the body's immune system ...

Patients with newly diagnosed gastric or gastroesophageal junction (GEJ) cancer who received the PD-L1 inhibitor durvalumab ...

The trial, in people treated for colon cancer, showed clear evidence that an exercise program lowered the risk of disease ...